{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:25:03Z","timestamp":1765887903201},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,8]]},"DOI":"10.18632\/oncotarget.19729","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T13:00:04Z","timestamp":1501506004000},"page":"64294-64302","source":"Crossref","is-referenced-by-count":10,"title":["MiR-30e-UCP2 pathway regulates alcoholic hepatitis progress by influencing ATP and hydrogen peroxide expression"],"prefix":"10.18632","volume":"8","author":[{"given":"Xi","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo-Sang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zun","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cld.2016.02.002","article-title":"Spectrum of alcoholic liver disease","volume":"20","author":"Reinus","year":"2016","journal-title":"Clin Liver Dis"},{"key":"2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/hepr.12736","article-title":"Pathogenesis of alcoholic liver disease","volume":"47","author":"Takei","year":"2017","journal-title":"Hepatol Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Croce","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.dld.2008.08.008","article-title":"MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease","volume":"41","author":"Li","year":"2009","journal-title":"Dig Liver Dis"},{"key":"6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1746.2011.06864.x","article-title":"Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways","volume":"27","author":"Li","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.fertnstert.2013.10.042","article-title":"MicroRNA: key gene expression regulators","volume":"101","author":"Simon","year":"2014","journal-title":"Fertil Steril"},{"key":"8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gutjnl-2016-311861","article-title":"MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils","volume":"66","author":"Gao","year":"2017","journal-title":"Gut"},{"key":"9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.29144","article-title":"miR181b-3p and its target importin alpha5 regulate TLR4 signaling in Kupffer cells and liver injury in mice in response to ethanol","volume":"66","author":"Nagy","year":"2017","journal-title":"Hepatology"},{"key":"10","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.3760\/cma.j.issn.0366-6999.20130940","article-title":"Uncoupling protein and nonalcoholic fatty liver disease","volume":"126","author":"Li","year":"2013","journal-title":"Chin Med J"},{"key":"11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.10.034","article-title":"HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD","volume":"50","author":"Li","year":"2009","journal-title":"J Hepatol"},{"key":"12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3748\/wjg.v23.i1.76","article-title":"miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism","volume":"23","author":"Xiang","year":"2017","journal-title":"World J Gastroenterol"},{"key":"13","first-page":"135","article-title":"The role of oxidative stress in the development of alcoholic liver disease","volume":"79","author":"Gutierrez-Reyes","year":"2014","journal-title":"Rev Gastroenterol Mex"},{"key":"14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ki.2013.80","article-title":"A microRNA-30e\/mitochondrial uncoupling protein 2 axis mediates TGF-beta1-induced tubular epithelial cell extracellular matrix production and kidney fibrosis","volume":"84","author":"Yang","year":"2013","journal-title":"Kidney Int"},{"key":"15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1574887111666160810101202","article-title":"Epidemiology and natural history of alcoholic liver disease","volume":"11","author":"Persico","year":"2016","journal-title":"Rev Recent Clin Trials"},{"key":"16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1751-2980.2010.00477.x","article-title":"Guidelines for the diagnosis and management of alcoholic liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 167-170)","volume":"12","author":"Shen","year":"2011","journal-title":"J Dig Dis"},{"key":"17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0034-1397347","article-title":"MicroRNAs in alcoholic liver disease","volume":"35","author":"Satishchandran","year":"2015","journal-title":"Semin Liver Dis"},{"key":"18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1530-0277.2009.01007.x","article-title":"MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice","volume":"33","author":"Szabo","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/liv.12196","article-title":"Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis","volume":"33","author":"Li","year":"2013","journal-title":"Liver Int"},{"key":"20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.toxlet.2015.03.002","article-title":"Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease","volume":"234","author":"Feng","year":"2015","journal-title":"Toxicol Lett"},{"key":"21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajpath.2015.10.003","article-title":"Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma","volume":"186","author":"Ray","year":"2016","journal-title":"Am J Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/onc.2016.491","article-title":"MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway","volume":"36","author":"Sun","year":"2017","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bbrc.2016.03.008","article-title":"MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA","volume":"472","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00424-012-1078-y","article-title":"TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice","volume":"463","author":"Zhu","year":"2012","journal-title":"Pflugers Arch"},{"key":"25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/labmed\/lmw052","article-title":"Association of UCP2 \u2212866G>A polymorphism with nonalcoholic fatty liver disease in patients from North-West of Iran","volume":"48","author":"Jafarabadi","year":"2017","journal-title":"Lab Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-0035-1550054","article-title":"Liver fibrosis in alcoholic liver disease","volume":"35","author":"Gao","year":"2015","journal-title":"Semin Liver Dis"},{"key":"27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jep.2014.12.013","article-title":"Protective effects of Penthorum chinense Pursh against chronic ethanol-induced liver injury in mice","volume":"161","author":"Wan","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"28","article-title":"The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride-treated mice","author":"Xu","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"29","doi-asserted-by":"crossref","first-page":"e0174218","DOI":"10.1371\/journal.pone.0174218","article-title":"Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:52:52Z","timestamp":1719352372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,8]]}},"alternative-id":["19729","28969071"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19729","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]}}}